Prostate Cancer Burden and Heterogeneity Evaluation Towards Liquid Biopsy: a Correlation Study to 18FDCFPyL PET and Patients Outcome
Latest Information Update: 15 Apr 2025
At a glance
- Drugs Lutetium (177Lu) vipivotide tetraxetan (Primary)
- Indications Prostate cancer
- Focus Diagnostic use; Proof of concept
- Acronyms TAYLOR
- 15 Apr 2025 New trial record